ProfileGDS4132 / 227116_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 37% 39% 42% 40% 40% 46% 42% 46% 42% 38% 41% 43% 44% 43% 39% 44% 43% 38% 40% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10193.693337
GSM201543Muscle PCOS pioglitazone 12193.623339
GSM201544Muscle PCOS pioglitazone 161111.80842
GSM201545Muscle PCOS pioglitazone 201111.11340
GSM201829Muscle PCOS pioglitazone 231111.78640
GSM201830Muscle PCOS pioglitazon 251126.0346
GSM201831Muscle PCOS pioglitazone 271110.89842
GSM201832Muscle PCOS pioglitazone 31120.10646
GSM201833Muscle PCOS pioglitazone 41103.41642
GSM201834Muscle PCOS pioglitazone 8194.398638
GSM201835Muscle PCOS after pioglitazone 10291.473441
GSM201836Muscle PCOS after pioglitazone 122101.7343
GSM201837Muscle PCOS after pioglitazone 16297.966444
GSM201838Muscle PCOS after pioglitazone 202101.76243
GSM201839Muscle PCOS after pioglitazone 23291.879339
GSM201840Muscle PCOS after pioglitazone 252110.83244
GSM201841Muscle PCOS after pioglitazone 27295.887843
GSM201842Muscle PCOS after pioglitazone 3279.428338
GSM201843Muscle PCOS after pioglitazone 4299.025840
GSM201844Muscle PCOS after pioglitazone 8292.269438